IBM Establishes Life Science Consulting Practice to Meet Anticipated Demand for IT Services | GenomeWeb

IBM is supplementing its life science offerings by establishing a consulting practice within its Global Services organization with the aim of helping biotech and pharmaceutical companies use information technology to speed development of medical treatments.

The new Global Life Sciences Consulting and Solutions unit will provide its existing and future life sciences partners with consultants who will advise them on systems integration and outsourcing in the areas of data management, knowledge management, and e-business services, IBM said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.